Hochschulschrift
Molecular adaptation and resistance mechanisms of human malignant glioma cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
21 cm
- Umfang
-
98 Seiten, 26 verschieden gezählte Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Enthält Sonderabdrucke
Eberhard Karls Universität Tübingen, Dissertation, 2018
- Ereignis
-
Veröffentlichung
- (wo)
-
Tübingen
- (wann)
-
2018
- Urheber
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 12:20 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Entstanden
- 2018
Ähnliche Objekte (12)
Adaptation mechanisms to stress factors of the tumor microenvironment in human malignant glioma cells
Nuclear adaptation to confinement-induced damage in malignant and non-malignant cells
Characterization of cancer treatment-related neurotoxicity in patients with malignant glioma
The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma
The Acidic Brain—Glycolytic Switch in the Microenvironment of Malignant Glioma
Histone deacetylase inhibitors reverse resistance to methylating agents : mechanisms in malignant melanoma and glioblastoma cells
Determinants of response and resistance to glioma immunotherapy
Regorafenib CSF penetration, efficacy, and MRI patterns in recurrent malignant glioma patients
Improving the Extent of Malignant Glioma Resection by Dual Intraoperative Visualization Approach
Vesicular stomatitis virus (VSV)-based systems for oncolytic virotherapy of malignant glioma
Gene therapy of malignant glioma with retroviral vectors and tumorinfiltrating progenitor cells
Pirfenidone, an inhibitor of TGF-beta expression in malignant glioma cell lines
Adaptation mechanisms to stress factors of the tumor microenvironment in human malignant glioma cells
Nuclear adaptation to confinement-induced damage in malignant and non-malignant cells
Characterization of cancer treatment-related neurotoxicity in patients with malignant glioma
The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma
The Acidic Brain—Glycolytic Switch in the Microenvironment of Malignant Glioma
Histone deacetylase inhibitors reverse resistance to methylating agents : mechanisms in malignant melanoma and glioblastoma cells
Determinants of response and resistance to glioma immunotherapy
Regorafenib CSF penetration, efficacy, and MRI patterns in recurrent malignant glioma patients
Improving the Extent of Malignant Glioma Resection by Dual Intraoperative Visualization Approach
Vesicular stomatitis virus (VSV)-based systems for oncolytic virotherapy of malignant glioma
Gene therapy of malignant glioma with retroviral vectors and tumorinfiltrating progenitor cells
Pirfenidone, an inhibitor of TGF-beta expression in malignant glioma cell lines
Adaptation mechanisms to stress factors of the tumor microenvironment in human malignant glioma cells
Nuclear adaptation to confinement-induced damage in malignant and non-malignant cells
Characterization of cancer treatment-related neurotoxicity in patients with malignant glioma
The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma
The Acidic Brain—Glycolytic Switch in the Microenvironment of Malignant Glioma
Histone deacetylase inhibitors reverse resistance to methylating agents : mechanisms in malignant melanoma and glioblastoma cells
Determinants of response and resistance to glioma immunotherapy
Regorafenib CSF penetration, efficacy, and MRI patterns in recurrent malignant glioma patients
Improving the Extent of Malignant Glioma Resection by Dual Intraoperative Visualization Approach
Vesicular stomatitis virus (VSV)-based systems for oncolytic virotherapy of malignant glioma
Gene therapy of malignant glioma with retroviral vectors and tumorinfiltrating progenitor cells